Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07284589 · ClinicalTrials.gov registry record · Phase 2
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
A Phase 2 study of Healthy Volunteers and Healthy (Controls), sponsored by Akiva Mintz.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07284589: Recruiting Phase 2 study of Healthy Volunteers and Healthy (Controls), sponsored by Akiva Mintz.
NCT07284589 is a Phase 2 study of Healthy Volunteers and Healthy (Controls) that is actively recruiting participants, run by Akiva Mintz. The registered enrollment target is 200 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07284589, a Phase 2 study of Healthy Volunteers and Healthy (Controls), is actively recruiting participants, sponsored by Akiva Mintz.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer that binds to a tumor specific protein called somatostatin receptor 2 (SSTR2) and be imaged on a new type of high sensitivity PET scanner for up to 3 hours
Primary Outcome
Measurement of signal-to-noise ratio for image quality assessment across different scan durations, reconstruction techniques, and artificial intelligence (AI)-enhanced image reconstructions. Unit of Measure: SNR (unitless, numeric ratio)
Conditions Studied
Interventions
- DRUG 68Ga-Dotatate
Study Locations (1)
New Jersey
- Nuclear Imaging Institute - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-12-11 |
| Est. Completion | 2030-04-30 |
| Phase | Phase 2 |
What NCT07284589 shows while recruiting
NCT07284589 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower).
The record links to 3 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which 68Ga-Dotatate is the first listed.
NCT07284589 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07284589 about?
NCT07284589 is a clinical study titled "Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake". The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconst...
What is the current status of trial NCT07284589?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2025-12-11. Estimated completion is 2030-04-30.
What conditions does trial NCT07284589 study?
This clinical trial studies the following conditions: Healthy Volunteers, Healthy (Controls), Neuroendocrine (NE) Tumors.
What interventions are being tested in trial NCT07284589?
The interventions under investigation include: 68Ga-Dotatate (DRUG).
Who is sponsoring clinical trial NCT07284589?
This trial is sponsored by Akiva Mintz, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07284589 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07284589's enrollment target sits among peer trials
200 48th of 283 higher than 236 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurobiology of Suicide
RECRUITING · Phase 2
-
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
RECRUITING · Phase 2
-
Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA
ACTIVE NOT RECRUITING · Phase 2
-
Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
COMPLETED · Phase 2
-
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
COMPLETED · Phase 2
-
Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI